MONDAY, Dec. 16, 2024 (HealthDay News) — The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast cancer, a new study says. Women who took tamoxifen after undergoing a lumpectomy to remove ductal carcinoma in situ (DCIS)Continue Reading

FRIDAY, Dec. 13, 2024 (HealthDay News) — An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows. The drug, imlunestrant, improved progression-free survival in patients whose breast cancer was driven by the female hormone estrogen. TheContinue Reading

FRIDAY, Dec. 13, 2024 (HealthDay News) — A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer. According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal carcinoma in situ (DCIS) resulted in breast cancer recurrenceContinue Reading

FRIDAY, Dec. 13, 2024 (HealthDay News) — The ancient Japanese practice of reiki “energy healing” might help some cancer patients deal with the pain that can come with infusion therapies, new research shows. “Outpatients receiving reiki during infusion reported clinically significant improvements in all symptoms, high levels of satisfaction andContinue Reading

THURSDAY, Dec. 12, 2024 (HealthDay News) — Sneaking cigarettes might seem like a harmless pre-teen rite of passage, but it’s more dangerous than you think, a new study warns.  Regular smoking at a young age doesn’t just lead to a higher chance of smoking later in life — it canContinue Reading

TUESDAY, Dec. 10, 2024 (HealthDay News) — Fatty, salty and sugary ultra-processed foods could be increasing people’s risk of colon cancer by spurring chronic inflammation in the gut. In a new study, colon tumors taken from people with poor diets had higher levels of pro-inflammatory biochemicals, as well as lowerContinue Reading

MONDAY, Dec. 9, 2024 (HealthDay News) — Two commonly used solvents that have been linked to cancer were banned Monday by the Environmental Protection Agency. The solvents, known as trichloroethylene (TCE) and perchloroethylene (Perc), are used in in cleaners, spot removers, lubricants, glue and automative care products. “It’s simply unacceptableContinue Reading